Bio SB Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Bio SB

Access the complete profile.

Bio SB Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	339112 Surgical & Medical Instrument Manufacturing
Address	5385 Hollister Ave Ste 108 Santa Barbara, CA 93111

Note: Revenues for privately held companies are statistical evaluations.


Bio SB's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Bio SB's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Bio SB is classified as operating in the Surgical & Medical Instrument Manufacturing industry, NAICS Code 339112.

Bio SB Annual Revenue and Growth Rate

Bio SB	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$10 - $100 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Bio SB's revenues are gauged from an analysis of company filings.

Bio SB's Income Statement (based on Industry Averages)

Bio SB P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Bio SB is developing and marketing. Bio SB doesn't have any recent trademark applications, indicating Bio SB is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TINTORETRIEVER Electric pressure cooker used for a variety of molecular pathology applications	12/09/2021
TINTODETECTOR Capillary Gap molecular pathology system for diagnostic and research laboratories consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology purposes in the medical diagnostics industry	12/09/2021
TINTOSTAINER Immunohistochemistry detection system consisting of mouse secondary reagents, DAB chromogens, DAB buffers, peroxidase blocking reagent, and hematoxylin, for anatomic pathology laboratory purposes in the medical diagnostics industry	12/09/2021

See all trademarks and details in the Full Report.

Market Share of Bio SB's Largest Competitors

A competitive analysis shows these companies are in the same general field as Bio SB, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
EMBECTA	Parsippany, NJ	100
STRUCTURE MEDICAL	Mooresville, NC	34
AUTOCAM MEDICAL DEVICES	Kentwood, MI	30
SCHARNBERG HOLDING	Des Moines, IA	26
SPECIALTY SURGICAL INSTRUMENTATION	Antioch, TN	24
MIDWEST INTERVENTIONAL SYSTEMS	Maple Grove, MN	19
VITA NEEDLE	Needham, MA	17
PYLANT MEDICAL	Grapevine, TX	17
MEDTEC	Orange City, IA	16

Nearby Competitors

These companies are similar in business line and location to Bio SB. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
COAST TO COAST CARDIOLOGY A VE	Santa Barbara, CA	100
INOGEN	Goleta, CA	78
KARL STORZ IMAGING	Goleta, CA	29
INTOUCH TECHNOLOGIES	Goleta, CA	21
SOL - MILLENNIUM MEDICAL	Santa Barbara, CA	6
BIO SB	Santa Barbara, CA	2

Future Competition: Bio SB's Fastest Growing Competitors

These companies are in the same general field as Bio SB and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)